肺癌合并症:自报与登记数据的队列研究
这项前瞻性队列研究纳入336例肺癌患者和125例疑癌但无癌患者,比较自报与登记来源的合并症数据质量。结果显示自报合并症显著低报,且仅登记数据结合简化合并症评分可检出与总生存的关联(HR=1.6,95%CI 1.0-2.5,p=0.03),校正后仍显著(HR=1.8,95%CI 1.1-3.3,p=0.028)。
要点
- 自报合并症较登记数据显著低报。
- 仅登记数据用简化合并症评分可检出与OS关联。
- 自报数据或Charlson指数未检出合并症与OS关联。
核心结论
- 在疑癌队列中,合并症估计因数据收集方法而异,且数据收集方法可能影响合并症与OS的关联。
研究设计与样本
- 前瞻性研究,评估自报与登记来源的配对合并症数据,并检验Charlson合并症指数和简化合并症评分对肺癌总生存的预测作用。
- 队列包括336例肺癌患者和125例疑癌但无癌患者。
主要发现
- 自报合并症较登记数据显著低报。
- 仅登记数据结合简化合并症评分可检出合并症与OS关联(HR=1.6,95%CI 1.0-2.5,p=0.03)。
- 校正相关临床病理特征后关联仍显著(HR=1.8,95%CI 1.1-3.3,p=0.028)。
- 使用自报数据或Charlson合并症指数均未检出合并症与OS关联。
临床怎么用
- 在肺癌合并症评估中,数据收集方法可能影响合并症与生存的关联分析,登记数据结合简化合并症评分或更适用于预后评估。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Comorbidity is a debated prognosticator in lung cancer. Results are conflicting, and the variety in study designs and inclusion criteria hampers direct comparison of available studies. So far, methods for generation of data on lung cancer comorbidity have attracted little attention. We evaluated whether self-reported comorbidity and register-based comorbidity are of comparable quality. METHODS: In a prospective study, we evaluated paired data sets on self-reported versus register-based comorbidity to detect whether any data asymmetry could be related to the data collection methods. We evaluated the Charlson comorbidity index and the simplified comorbidity score as predictors of overall survival (OS) in lung cancer to test whether our findings would affect outcome. RESULTS: In a cohort of 336 patients with lung cancer and 125 patients in whom cancer was suspected but who were determined to be cancer-free, we demonstrated a significant underreporting of self-reported comorbidities compared with register-based comorbidities. Furthermore, we demonstrated that an association between comorbidity and OS can be detected only by using register-based data and only by the simplified comorbidity score (hazard rate = 1.6, 95% confidence interval: 1.0-2.5, p = 0.03). The results remained significant after adjustment for the relevant clinicopathological characteristics (hazard rate = 1.8, 95% confidence interval: 1.1-3.3, p = 0.028). An association between comorbidity and OS could not be detected by using either the self-reported data or the Charlson comorbidity index. CONCLUSIONS: In this cohort of patients in whom cancer was suspected, comorbidity estimations varied depending on the data collection method used; similarly, the data collection method could affect the association between comorbidity and OS.
引用
- Sandfeld-Paulsen B, Meldgaard P, Aggerholm-Pedersen N, et al. Comorbidity in Lung Cancer: A Prospective Cohort Study of Self-Reported versus Register-Based Comorbidity. J Thorac Oncol. 2017. PMID: 29056534. doi:10.1016/j.jtho.2017.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。